ライフサイエンスコーパス: cerebrospinal

1 igh frequency of gene mutations in pediatric cerebrospinal AVFs, and show the predominance of RASA1 o

2 eta42, and tau proteins are established core cerebrospinal biomarkers; novel candidate biomarkers inc

3 nd a low white blood cell count on the first cerebrospinal examination (odds ratio, 9.83 for <5 vs. >

4 throat swabs (33 of 39 [85%]) rather than in cerebrospinal fluid (10 of 41 [24%]).

5 bic wounds (30%), blood (5.5%), urine (22%), cerebrospinal fluid (24%), ophthalmologic cultures (8%),

6 ds, from salty biofluids such as aritificial cerebrospinal fluid (aCSF) and serum.

7 nal fluid (hCSF), using a matched artificial cerebrospinal fluid (aCSF) as control.

8 types of microorganisms spiked in artificial cerebrospinal fluid (ACSF) were directly detected simult

9 imal were pre-incubated in normal artificial cerebrospinal fluid (aCSF) while half were pre-incubated

10 tment 1), extracellular (compartment 2), and cerebrospinal fluid (compartment 3).

11 se in the released form of galectin-3 in the cerebrospinal fluid (CSF) 24 h after head injury.

12 plaques as evidenced by amyloid imaging and cerebrospinal fluid (CSF) Abeta1-42 (Abeta42) is an earl

13 mptoms (N=331) in the BioFINDER study, using cerebrospinal fluid (CSF) Abeta40 as a surrogate for amy

14 infected participants enrolled in a study of cerebrospinal fluid (CSF) abnormalities in syphilis unde

15 We studied whether continuous lower normal cerebrospinal fluid (CSF) amyloid beta1-42 (>/=640pg/ml)

16 tin C-Terminal Hydrolase L1 (UCHL1) in mouse cerebrospinal fluid (CSF) and Abeta in the mouse brains.

17 and neurofilament levels were determined in cerebrospinal fluid (CSF) and blood and analysed with re

18 iewing the literature to date on the role of cerebrospinal fluid (CSF) and blood biomarkers, we highl

19 peptide secondary structure distribution in cerebrospinal fluid (CSF) and blood plasma of 141 patien

20 p between SVD, multiple isoforms of Abeta in cerebrospinal fluid (CSF) and cortical Abeta in 831 subj

21 as a system that allows CNS perfusion by the cerebrospinal fluid (CSF) and interstitial fluid (ISF).

22 Here we show that ZIKV can persist in cerebrospinal fluid (CSF) and lymph nodes (LN) of infect

23 iral RNA was also detected in saliva, urine, cerebrospinal fluid (CSF) and semen, but transiently in

24 Neurofilaments are elevated in the cerebrospinal fluid (CSF) and serum of amyotrophic later

25 elin Basic Protein (MBP) and Tau proteins in cerebrospinal fluid (CSF) and serum, obtained from Multi

26 yloid precursor protein (APP) are present in cerebrospinal fluid (CSF) and their potential as biomark

27 We also examined cerebrospinal fluid (CSF) biomarker measures for patient

28 mpal volume, normalized whole-brain volume), cerebrospinal fluid (CSF) biomarkers (amyloid-beta1-42,

29 ical disease, we sought to determine whether cerebrospinal fluid (CSF) biomarkers are intraindividual

30 bar punctures were performed and assayed for cerebrospinal fluid (CSF) biomarkers of AD pathology, in

31 levels of differentially abundant genera and cerebrospinal fluid (CSF) biomarkers of AD.

32 The data show that LXR is a regulator of cerebrospinal fluid (CSF) both at the choroid plexus and

33 In hydrocephalus, cerebrospinal fluid (CSF) builds up in the cranial cavit

34 detection of human cytomegalovirus (hCMV) in cerebrospinal fluid (CSF) by polymerase chain reaction (

35 we showed that abnormal levels of Abeta42 in cerebrospinal fluid (CSF) can be detected before abnorma

36 min B6 (pyridoxal phosphate (PLP))) in human cerebrospinal fluid (CSF) can be used as indicators of t

37 The primary outcome was 2-week cerebrospinal fluid (CSF) clearance rate of cryptococcus

38 he absence of markers of inflammation in the cerebrospinal fluid (CSF) commonly predicts the absence

39 In the present study, cerebrospinal fluid (CSF) concentrations of GABA were an

40 Notably, cerebrospinal fluid (CSF) contains microRNAs that may se

41 Cerebrospinal fluid (CSF) continuously flows through the

42 of 10 LFA-positive cases agreeing to LP, the cerebrospinal fluid (CSF) CrAg LFA was positive.

43 quency and/or a delay in the positivity of a cerebrospinal fluid (CSF) culture or CSF antibody, parti

44 hile the concentration of Abeta(1-42) in the cerebrospinal fluid (CSF) decreases in APPswe, PS1M146V

45 central nervous system, resulting in either cerebrospinal fluid (CSF) discordance (viral load [VL] i

46 ts, perhaps owing to persistent HIV-1 RNA in cerebrospinal fluid (CSF) during antiretroviral therapy

47 nt diagnostic criteria involving analysis of cerebrospinal fluid (CSF) for parasites and/or pleocytos

48 study, we performed metabolomics analysis of cerebrospinal fluid (CSF) from cognitively intact elderl

49 undred twenty-two C57BL/6J mice infused with cerebrospinal fluid (CSF) from patients with anti-NMDAR

50 he apoE isoform amounts are not different in cerebrospinal fluid (CSF) from young normal controls, su

51 (>/= 55%), absent or low titers of serum and cerebrospinal fluid (CSF) immunoglobulin M, and occasion

52 We performed detailed neurological exams, cerebrospinal fluid (CSF) immunophenotyping and biomarke

53 her pyrimethamine lowered SOD1 levels in the cerebrospinal fluid (CSF) in patients carrying SOD1 muta

54 autism spectrum disorder (ASD) had increased cerebrospinal fluid (CSF) in the subarachnoid space (i.e

55 Plasma and cerebrospinal fluid (CSF) inflammatory markers were asse

56 5, and inflammatory phenotype was defined by cerebrospinal fluid (CSF) leukocyte and cytokine concent

57 LTA4H promoter polymorphism, which predicted cerebrospinal fluid (CSF) leukocyte count and survival o

58 eak positive correlations between plasma and cerebrospinal fluid (CSF) levels for both Abeta42 and Ab

59 We investigated whether plasma or cerebrospinal fluid (CSF) levels of cytokines and chemok

60 Elevated cerebrospinal fluid (CSF) levels of the glia-derived N-m

61 l protein that has demonstrated utility as a cerebrospinal fluid (CSF) marker of synaptic loss in AD.

62 Biological variables included cerebrospinal fluid (CSF) markers and dopamine transport

63 he innate immune system, was associated with cerebrospinal fluid (CSF) markers of neuronal injury in

64 Blood and cerebrospinal fluid (CSF) of children with TBM and hydro

65 High levels of G6 dendrimers were found in cerebrospinal fluid (CSF) of injured animals with a CSF/

66 nt heavy chain (pNfH) levels are elevated in cerebrospinal fluid (CSF) of patients with amyotrophic l

67 in levels were significantly elevated in the cerebrospinal fluid (CSF) of Plxna4(-/-) mice and, in hu

68 Existing cerebrospinal fluid (CSF) or imaging (tau positron emiss

69 e symptoms and measles antibody detection in cerebrospinal fluid (CSF) or medical record documentatio

70 disease-specific pathologic prion protein in cerebrospinal fluid (CSF) or olfactory mucosa (OM) sampl

71 Although studies have shown increased cerebrospinal fluid (CSF) OT levels following IN adminis

72 Cerebrospinal fluid (CSF) pleocytosis (>5 white blood ce

73 SCS patients had constitutional symptoms, cerebrospinal fluid (CSF) pleocytosis, and hilar adenopa

74 orylated neurofilament heavy chain (pNFH) in cerebrospinal fluid (CSF) predict disease status and sur

75 sually self-limiting condition caused by low cerebrospinal fluid (CSF) pressure, usually due to CSF l

76 fied XCAT phantom with additional and edited cerebrospinal fluid (CSF) regions to produce voxel-level

77 zed symptoms and signs, and neuroimaging and cerebrospinal fluid (CSF) results.

78 We examined longitudinal cerebrospinal fluid (CSF) samples (median, 5 samples/pat

79 ting Xpert MTB/RIF diagnostic performance on cerebrospinal fluid (CSF) samples are lacking in resourc

80 Here, using cerebrospinal fluid (CSF) samples from 239 patients with

81 During this period, serum and/or cerebrospinal fluid (CSF) samples from 3,969 patients we

82 High throughput metabolite screening of cerebrospinal fluid (CSF) samples from a canine model of

83 myloid1-42 (Abeta) levels were determined in cerebrospinal fluid (CSF) samples from all patients and

84 ing strategy to procure bone marrow (BM) and cerebrospinal fluid (CSF) samples from May 1, 2007, thro

85 al of 363 patients with HSV PCR results from cerebrospinal fluid (CSF) samples were included in this

86 Infant cerebrospinal fluid (CSF) samples were tested for ZIKV-s

87 tion (PCR) testing for Treponema pallidum in cerebrospinal fluid (CSF) samples.

88 We prospectively obtained diagnostic cerebrospinal fluid (CSF) specimens during screening for

89 and neonates with microcephaly and collected cerebrospinal fluid (CSF) specimens from 30 neonates.

90 Archival serum or cerebrospinal fluid (CSF) specimens were available from

91 strategy, defined as the absence of definite cerebrospinal fluid (CSF) sterilization or related morta

92 Cerebrospinal fluid (CSF) tau is an excellent surrogate

93 To test the hypotheses that (1) antemortem cerebrospinal fluid (CSF) tau levels correlate with post

94 ency virus (HIV) infection by evaluating the cerebrospinal fluid (CSF) to serum albumin quotient (QAl

95 tral distribution of macromolecules from the cerebrospinal fluid (CSF) to the brain and spinal cord r

96 asculature and the path of drainage from the cerebrospinal fluid (CSF) to the lymphatics remain poorl

97 We measured cerebrospinal fluid (CSF) tryptophan and kynurenine meta

98 lly was observed in animals with episodes of cerebrospinal fluid (CSF) viral rebound or sustained pla

99 pants with low or undetectable plasma VL and cerebrospinal fluid (CSF) VL prior to death who were enr

100 re unique to neuronal cells, are shed to the cerebrospinal fluid (CSF), and are detectable at low con

101 monocyte subpopulations in peripheral blood, cerebrospinal fluid (CSF), and brain biopsy material der

102 issues or prior probability maps (nlTPMs) of cerebrospinal fluid (CSF), gray matter (GM), and white m

103 ave been proposed for detection of prions in cerebrospinal fluid (CSF), most recently, the measuremen

104 which are diagnosed by detection of JCPyV in cerebrospinal fluid (CSF), often with the support of cer

105 The 102 included patients had: (1) serum, cerebrospinal fluid (CSF), or both that yielded a charac

106 ssion from MCI to AD were found for abnormal cerebrospinal fluid (CSF), phosphorylated tau (p-tau) (r

107 ngeal metastasis, or spread of cancer to the cerebrospinal fluid (CSF), which is a frequent and fatal

108 Current cerebrospinal fluid (CSF)- or imaging-based single bioma

109 notherapeutics) access brain tissue from the cerebrospinal fluid (CSF).

110 tin in the blood and translocate it into the cerebrospinal fluid (CSF).

111 eloped to measure beta-amyloid (Abeta) 42 in cerebrospinal fluid (CSF).

112 whether circulating NMDAR1 AB appear in the cerebrospinal fluid (CSF).

113 he ionic constituency of the bathing medium [cerebrospinal fluid (CSF)], or by electrical stimulation

114 ubsequent placement of an LD for drainage of cerebrospinal fluid (CSF; intervention group).

115 ls (PBMCs; n = 72), seminal plasma (n = 20), cerebrospinal fluid (CSF; n = 36), dried blood spots (DB

116 Human cerebrospinal fluid (hCSF) substantially increases the e

117 om pyramidal cells, in the presence of human cerebrospinal fluid (hCSF), using a matched artificial c

118 we characterize exosomes directly from human cerebrospinal fluid (hCSF).

119 s and the frequencies of immune cells in the cerebrospinal fluid (including B cells, T cells, and nat

120 Total cerebrospinal fluid (median, 47.6 mL [35.1-69.4 mL] to 6

121 lesterol was confirmed in serum (n = 19) and cerebrospinal fluid (n = 17) of SPG5 patients.

122 levels of 38 mediators in serum (n = 78) and cerebrospinal fluid (n = 37) specimens from patients wit

123 leacetic acid (5-HIAA) concentrations in the cerebrospinal fluid 12 months after gene therapy.

124 In cerebrospinal fluid 27-hydroxycholesterol was reduced by

125 lt Malawian patients with ABM (n = 523 [65%] cerebrospinal fluid [CSF] culture positive).

126 Localization of a cerebrospinal fluid [CSF] fistula is a diagnostic challe

127 osinor measures of each participant's serial cerebrospinal fluid Abeta concentrations and Abeta turno

128 the diurnal fluctuations in interstitial and cerebrospinal fluid Abeta levels observed in both the ro

129 ocial cognition and behavior, accumulates in cerebrospinal fluid after intranasal administration in m

130 lfonylurea receptor-1 is measurable in human cerebrospinal fluid after severe traumatic brain injury

131 the exchange of brain interstitial fluid and cerebrospinal fluid along a brain-wide network of periva

132 ll, players with PCS had significantly lower cerebrospinal fluid amyloid-beta levels compared with co

133 vement of the medial temporal lobe, abnormal cerebrospinal fluid amyloid-beta1-42 values, and proport

134 ls based on biomarkers of amyloid pathology (cerebrospinal fluid amyloid-beta42/amyloid-beta40 assay

135 = 5) or vitreous humor (n = 2) analysis and cerebrospinal fluid analysis (n = 2).

136 mination, 4.1 [0.7] months), 7 who underwent cerebrospinal fluid analysis for ZIKV had positive findi

137 Cerebrospinal fluid analysis was abnormal in 9 of 12 pat

138 sonance imaging, electroencephalography, and cerebrospinal fluid analysis) and molecular data (prion

139 etagenomic next generation sequencing of his cerebrospinal fluid and brain biopsy tissue was performe

140 test further these small molecules in human cerebrospinal fluid and in a Caenorhabditis elegans mode

141 , cis P-tau is induced in cortical axons and cerebrospinal fluid and positively correlates with axona

142 Total cerebrospinal fluid and ventricular volume change may be

143 ll subsets and immunoglobulin indices in the cerebrospinal fluid and whether retinal layer volumes al

144 Oligoclonal Ig bands (OCBs) of the cerebrospinal fluid are a hallmark of multiple sclerosis

145 ron emission tomography amyloid imaging or a cerebrospinal fluid assay of amyloid beta.

146 11-labeled Pittsburgh Compound B (PiB), and cerebrospinal fluid assays of tau and phosphorylated tau

147 ividuals, elevated brain amyloid (defined by cerebrospinal fluid assays or positron emission tomograp

148 nds, Propionibacterium species in joints and cerebrospinal fluid associated with central nervous syst

149 Moreover, microinjection of artificial cerebrospinal fluid at a pH of 6.5 into the VLM increase

150 ssed by endothelial cells of the mouse blood-cerebrospinal fluid barrier and of the blood-leptomening

151 ealthy CNS by endothelial cells of the blood-cerebrospinal fluid barrier and of the spinal cord menin

152 strate that leukemic cells transit the blood-cerebrospinal fluid barrier situated close to the dural

153 associated with brain injury as evaluated by cerebrospinal fluid biochemical markers for axonal damag

154 RI, amyloid positron emission tomography and cerebrospinal fluid biomarker analysis.

155 previously identified proSAAS as a potential cerebrospinal fluid biomarker in various neurodegenerati

156 out to have the least abnormal cognitive and cerebrospinal fluid biomarker profiles and the slowest c

157 heimer's disease neuroanatomical, cognitive, cerebrospinal fluid biomarkers and clinical profile, who

158 When ND was defined using cerebrospinal fluid biomarkers, individuals with stage 2

159 We relate these neuroimaging patterns to cerebrospinal fluid biomarkers, white matter hyperintens

160 DS cohort, using multimodal neuroimaging and cerebrospinal fluid biomarkers.

161 the amount of tau tracer uptake to levels of cerebrospinal fluid biomarkers.

162 Apolipoprotein E isolated from human cerebrospinal fluid carries sulfatide that can be captur

163 evidence exists that differences in blood or cerebrospinal fluid chemokine concentration discriminate

164 ctivity disruption during polysomnogram, and cerebrospinal fluid collection the following morning for

165 Serial cerebrospinal fluid collection via indwelling lumbar cat

166 96% (27 of 28) had cryptococcal meningitis (cerebrospinal fluid CRAG-positive) whereas 50% (7 of 14)

167 All infants had either cerebrospinal fluid cultures or 7-day follow-up.

168 erences (blood CCL5, CCL7, CXCL9, CXCL10 and cerebrospinal fluid CXCL8 and CXCL10).

169 Cerebrospinal fluid data from all 37 laboratories perfor

170 based on immediate and sustained response to cerebrospinal fluid diversion.

171 f meningeal LVs should allow manipulation of cerebrospinal fluid drainage and neuropathological proce

172 s or situations: cerebrospinal fluid shunts, cerebrospinal fluid drains, implantation of intrathecal

173 Subsequent edema can hinder cerebrospinal fluid efflux and can lead to locally incre

174 They are found in the cerebrospinal fluid even in the absence of inflammation;

175 ther supportive information is obtained from cerebrospinal fluid examination and neurophysiological t

176 Cerebrospinal fluid examination revealed mildly elevated

177 Serial cerebrospinal fluid examinations were consistent with ch

178 the formation of ependymal cells, disrupting cerebrospinal fluid flow and causing hydrocephalus.

179 lper T-cell subsets from peripheral blood or cerebrospinal fluid for cytokine production, gene expres

180 Testing of cerebrospinal fluid for ZIKV using IgM antibody-capture

181 We analyzed cerebrospinal fluid from 32 cases, 40 subjects with mult

182 The endopeptidome of cerebrospinal fluid from 40 Alzheimer's disease (AD) pat

183 ve proteomics to identify protein changes in cerebrospinal fluid from children with Streptococcus pne

184 to have an altered consciousness and higher cerebrospinal fluid fungal burden at presentation.

185 Higher cerebrospinal fluid HTLV-1 proviral load (p = 0.01) was

186 ci) and possibly promoted by low flow of the cerebrospinal fluid in these areas.

187 iagnosis, exercise-induced miRNA patterns in cerebrospinal fluid indicated distinct mechanisms for po

188 hether meningitis is present and analysis of cerebrospinal fluid is essential for diagnosis.

189 ons, vital signs, clinical laboratory tests, cerebrospinal fluid laboratory tests, and electrocardiog

190 We assessed for surgical complications (cerebrospinal fluid leakage and intracerebral haemorrhag

191 monomeric glycoprotein, is known to indicate cerebrospinal fluid leakage.

192 hetical preclinical AD groups using baseline cerebrospinal fluid levels of Abeta and tau or Abeta and

193 e lateral temporal lobe, and lower mean (SD) cerebrospinal fluid levels of tau (59.2 [32.8] vs 111.3

194 rmal expression of Keratin 9 in AD blood and cerebrospinal fluid may be a result of blood brain barri

195 tic end feet and defects in the synthesis of cerebrospinal fluid may be targeted by LXR agonists to f

196 adjusted for magnetic resonance imaging and cerebrospinal fluid measurements, sCD27 levels were asso

197 ntal cortices is correlated with tau-related cerebrospinal fluid measures.

198 Conclusions and Relevance: Increased cerebrospinal fluid neurofilament light proteins and red

199 Cerebrospinal fluid NFL concentration (median [interquar

200 Cerebrospinal fluid NFL concentration is increased by th

201 biomarker in ALS and the prognostic value of cerebrospinal fluid NFL in patients with ALS.

202 ethyl-D-aspartate receptor antibodies in the cerebrospinal fluid of 1 patient.

203 t here altered levels of gangliosides in the cerebrospinal fluid of amyotrophic lateral sclerosis pat

204 a markedly disturbed immune signature in the cerebrospinal fluid of cases that is consistent with imm

205 at shed PrP(c) (sPrP(c)) is increased in the cerebrospinal fluid of HIV-infected people with cognitiv

206 observed an increase in ACE2 activity in the cerebrospinal fluid of hypertensive patients, which was

207 ence essential for JCV neurovirulence and in cerebrospinal fluid of immunosuppressed patients with mu

208 f DN and CD21(low) B cells were found in the cerebrospinal fluid of MS patients compared with paired

209 influenza-infected mice and was elevated in cerebrospinal fluid of MS patients during relapse compar

210 even in the absence of inflammation; in the cerebrospinal fluid of MS patients they occur at a frequ

211 tion marker soluble CD27 (sCD27) measured in cerebrospinal fluid of patients at time of a first attac

212 The cerebrospinal fluid of patients with active MS was enric

213 Soluble CD27 in cerebrospinal fluid of patients with CIS was associated

214 individual neurotropic JCPyV strains in the cerebrospinal fluid of patients with PML.

215 in VH4-containing genes in B cells from the cerebrospinal fluid of patients with relapsing remitting

216 s from laboratory studies were notable for a cerebrospinal fluid opening pressure of 28 mm H2O and 8

217 xperience with the safety, tolerability, and cerebrospinal fluid penetration of the Src family kinase

218 ippocampal volume), neurofibrillary tangles (cerebrospinal fluid phosphorylated tau181 assay levels),

219 cteristics, including non-motor symptoms and cerebrospinal fluid phosphorylated-tau/total-tau ratio.

220 t with the homozygous PNPO variant had a low cerebrospinal fluid pyridoxal-5-phosphate level.

221 N/MCP, DN-to-pons, GP-to thalamus, and GP-to-cerebrospinal fluid ratios were measured and compared by

222 Dural cerebral veins (CV) are required for cerebrospinal fluid reabsorption and brain homeostasis,

223 underpinning mechanisms include the role of cerebrospinal fluid regulation as well as metabolic and

224 In the cerebrospinal fluid sample of a 73-year-old woman with r

225 ologic and molecular testing using blood and cerebrospinal fluid samples can serve as a less expensiv

226 evel of tumor necrosis factor-alpha in those cerebrospinal fluid samples confirmed that ADAM17 was up

227 Examination of cerebrospinal fluid samples detected lymphomatous mening

228 osorbent assay for ZIKV was performed on the cerebrospinal fluid samples of 7 of the 8 infants (88%),

229 Serum samples of cases and controls and cerebrospinal fluid samples of cases were tested for Zik

230 A total of 119 cerebrospinal fluid samples were collected from 28 sever

231 Cerebrospinal fluid samples were obtained from 176 patie

232 is presentation and found Ebola virus in all cerebrospinal fluid samples.

233 female (66.7%).Patients with CIS had higher cerebrospinal fluid sCD27 levels than control individual

234 er CRD (HR, 1.07; 95% CI, 1.03 to 1.11), and cerebrospinal fluid shunting (HR, 2.02; 95% CI, 1.07 to

235 fter the following procedures or situations: cerebrospinal fluid shunts, cerebrospinal fluid drains,

236 Among 4301 cerebrospinal fluid specimens tested, 1603 (37.3%) were

237 Most of the serum and cerebrospinal fluid studies were unremarkable.

238 fonylurea receptor-1 is available, assessing cerebrospinal fluid sulfonylurea receptor-1 in larger st

239 This is the first report quantifying human cerebrospinal fluid sulfonylurea receptor-1.

240 Cerebrospinal fluid testing was less sensitive than seru

241 f specific IgM antibodies in either blood or cerebrospinal fluid that appear in the second phase of t

242 post sacrifice and maintained in artificial cerebrospinal fluid to create near-physiological conditi

243 monkeys, where it achieved 10-fold enhanced cerebrospinal fluid to plasma ratio versus DON.

244 Transthyretin (TTR) is a blood and cerebrospinal fluid transporter of thyroxine and retinol

245 Limited data suggest that the cerebrospinal fluid Treponema pallidum particle agglutin

246 Soluble CD27 levels were determined in cerebrospinal fluid using a commercially available enzym

247 crease was associated with increase in total cerebrospinal fluid volume (r = 0.83, p < 0.001), and ch

248 quantitative technique to measure brain and cerebrospinal fluid volume changes.

249 e (r = 0.83, p < 0.001), and change in total cerebrospinal fluid volume was associated with ventricul

250 Associations among total cerebrospinal fluid volume, ventricular volume, serum so

251 ing brain-predicted age with grey matter and cerebrospinal fluid volumes (themselves strong predictor

252 Fungal clearance in cerebrospinal fluid was slower in the dexamethasone grou

253 itive RT-PCR results), although 3 samples of cerebrospinal fluid were also positive.

254 MicroRNAs (miRNA) in cerebrospinal fluid were amplified by quantitative PCR.

255 ension and the soluble CD14 concentration in cerebrospinal fluid were associated with lower fractiona

256 MIF levels in the cerebrospinal fluid were associated with systemic compli

257 Samples of serum and cerebrospinal fluid were tested for ZIKV using real-time

258 t contains a solution that closely resembles cerebrospinal fluid with the addition of extracellular m

259 s typically confined to the brain, eyes, and cerebrospinal fluid without evidence of systemic spread.

260 ce showed substantial levels of scFvs in the cerebrospinal fluid without significant effects on total

261 physiological fluids (blood, saliva, urine, cerebrospinal fluid) and brain tissue, it is unclear whe

262 cognitive, biomarker (structural imaging and cerebrospinal fluid) and other PD psychosis risk factor

263 Pittsburgh compound B and centrally analysed cerebrospinal fluid, a minority of subjects showed disco

264 nt mice, and IL-1beta is found in the blood, cerebrospinal fluid, and CNS lesions of MS patients.

265 cipation, decreased DA and DA metabolites in cerebrospinal fluid, and decreased availability, and rel

266 after acute SCI, and were detected in serum, cerebrospinal fluid, and in the injured tissue.

267 apeutic drug concentrations in the brain and cerebrospinal fluid, and that non-cross-resistant drugs

268 reatly to exosomal microRNAs (miRNAs) in the cerebrospinal fluid, and these exosomal miRNAs declined

269 be the effects of complex biofluids, such as cerebrospinal fluid, and thus has wide applicability.

270 Clinical specimens (blood, cerebrospinal fluid, and urine) and environmental specim

271 -reaction (RT-PCR) assays for ZIKV in blood, cerebrospinal fluid, and urine, as well as antiflaviviru

272 eference for a novel face) robustly predicts cerebrospinal fluid, but not blood, oxytocin concentrati

273 lium (CPE) secretes higher volumes of fluid (cerebrospinal fluid, CSF) than any other epithelium and

274 (+) T cells pervade lymphatic organs and the cerebrospinal fluid, have a strong ability to produce di

275 des quantitative data on the dynamics of the cerebrospinal fluid, it can help test new therapies and

276 High TSPyV loads in blood and cerebrospinal fluid, sometimes coinciding with cerebral

277 umes of whole brain, tissue compartments and cerebrospinal fluid, to test the hypothesis that HCA is

278 genic bacteria in positive culture of blood, cerebrospinal fluid, urine, or stool samples, including

279 Cerebrospinal fluid-contacting (CSF-c) cells containing

280 e B cells, and a neuronal-like population of cerebrospinal fluid-contacting cells.

281 rived measures of neurodegeneration/atrophy (cerebrospinal fluid-to-brain volume ratio, and hippocamp

282 giotensin II into angiotensin-(1-7) in human cerebrospinal fluid.

283 lepsy, and elevated lactate in the blood and cerebrospinal fluid.

284 r discovery and validates its feasibility on cerebrospinal fluid.

285 persistence were observed in bone marrow and cerebrospinal fluid.

286 of recent ZIKV infection in the serum and/or cerebrospinal fluid.

287 in the inflammatory milieu of the serum and cerebrospinal fluid.

288 the mammalian brain as well as in the human cerebrospinal fluid.

289 n MRI; positive spinal cord MRI; or positive cerebrospinal fluid.

290 is present at notably high concentrations in cerebrospinal fluid.

291 16 bacterial, viral, and fungal pathogens in cerebrospinal fluid.

292 lated tau, and neurogranin concentrations in cerebrospinal fluid.

293 erneuron activity in human versus artificial cerebrospinal fluid.

294 ts applied intranasally appears to reach the cerebrospinal fluid.

295 cell repertoires in the primary melanoma and cerebrospinal fluid.

296 d IL-1beta levels were elevated in serum and cerebrospinal fluid.

297 termination and the transport of gametes and cerebrospinal fluid.

298 tects multiple pathogens simultaneously from cerebrospinal fluid.

299 .20%]) and intrathecal IgG synthesis (median cerebrospinal fluid/serum IgG index, 0.78 [IQR, 0.53-1.0

300 rmacokinetic findings of approximately 0.001 cerebrospinal fluid:plasma ratio further supported limit